Selected News from Today's FirstWord

India introduces new drug pricing policy, with some set to fall up to 80 percent

India has introduced a new policy that will regulate the prices of 652 medicines in the country, including 348 essential drugs, an increase over the 74 bulk drugs and their formulations that are Full story

• Lundbeck’s Brintellix Is More Effective in Higher Dose in Study - (Ref. Bloomberg; Chicago Tribune; GlobeNewswire; PR Newswire)
• EMA committee backs Bayer's Diane-35 in certain patients - (Ref. The Courier-Mail; Bayer; EMA; Breitbart; Chicago Tribune; Romandie; Die Welt)
• Sanofi to overhaul Toulouse research site - (Ref. Sanofi; BusinessWeek; Bloomberg; Yahoo!News; Le Monde; FOX Business)
• GlaxoSmithKline looks to price cuts to boost emerging market growth: report - (Ref. Bloomberg)
• Sanofi to seek approval of myelofibrosis drug SAR302503 after positive Phase III data - (Ref. Sanofi; SmartMoney; Yahoo!News; NASDAQ; FinanzNachrichten; StreetInsider)

Also in the News

• Products:
• Combivent Respimat,
• Erbitux,
• ketamine,
• levodopa,
• nintedanib,
• RV144,
• tiotropium

• Companies:
• AbbVie,
• Alnylam,
• Boehringer Ingelheim,
• GSK,
• Paladin,
• Roche,
• Sanitas

• Markets:
• Australia,
• EU,
• United States,
• World

Most Read Stories in the Past Week

• Novartis CEO discusses plans for Diovan patent expiration
• Pfizer records 5-percent rise in second-quarter profit
• Pfizer may introduce OTC version of Lipitor, sources say
• NICE provisionally rejects Novartis' oral MS drug Gilenya
• HHS drops case against Forest CEO